---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-026645"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2026-03-12T23:59:59+00:00"
generated_at: "2026-05-15T13:52:50.619523+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Incannex Healthcare announces $10M registered direct offering of 2M shares and warrants at $5.00/unit

## Summary
- Offering consists of 2,000,000 shares (or equivalents) and 2,000,000 common warrants; combined price $5.00 per share and accompanying warrant.
- Gross proceeds ~$10M; warrants exercisable at $6.50 for 5 years; potential additional $13M if fully exercised.
- Proceeds expected to fund Phase 2 DReAMzz study for IHL-42X; prior cash on hand reserved for Phase 3 anticipated in H2 2027.
- Company terminated its at-the-market facility and does not intend to use ATM near term.
- Offering expected to close March 13, 2026; Curvature Securities acted as sole placement agent.

## SEC filing metadata
- accession: 0001213900-26-026645
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2026-03-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390026026645/0001213900-26-026645-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390026026645/ea0278296-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-026645
- JSON: https://secwatch.observer/filing/0001213900-26-026645.json
- Plain text: https://secwatch.observer/filing/0001213900-26-026645.txt

## Key facts
- Material Agreements
  Incannex Healthcare Inc. entered into Placement Agent Agreement with Curvature Securities, LLC (effective 2026-03-12).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Curvature Securities, LLC
  - Effective: 2026-03-12
  source text: On March 12, 2026, the Company entered into a placement agency agreement (the “Placement Agent Agreement”) with Curvature Securities, LLC (“Curvature” or the “Placement Agent”) pursuant to which the Company engaged Curvature as the sole placement agent in connection with the Offering.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1873875/000121390026026645/0001213900-26-026645-index.htm
- Material Agreements
  Incannex Healthcare Inc. entered into Securities Purchase Agreement with certain institutional investors valued at approximately $10 million (effective 2026-03-12).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Value: approximately $10 million
  - Effective: 2026-03-12
  source text: On March 12, 2026, Incannex Healthcare Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a registered direct offering (the “Offering”) by the Company directly to the Investors (the “Registered Offering”), (i) an aggregate of 1,997,285 shares of its common stock, par value $0.0001 per share (such shares, the “Shares”; such stock, the “Common Stock”), (ii) pre-funded warrants to purchase up to 2,715 shares of its Common Stock (the “Pre-Funded Warrants”), and (iii) common stock warrants to purchase up to 2,000,000 shares of its common stock (the “Common Warrants”) at a combined purchase price of $5.0 per Share and accompanying Common Warrant, or $4.9999 per Pre-Funded Warrant and accompanying Common Warrant.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1873875/000121390026026645/0001213900-26-026645-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.